1
Zamierowski David S: Fastening system and method. Zamierowski David S, BROWN Mark E, November 26, 1992: WO/1992/020299 (15 worldwide citation)

A fastening system (2) includes a membrane assembly (10) which can comprise a pair of body panels (16) secured together at a seam (27). The membrane panels can comprise a semi-permeable material. A sheath assembly (12) has a tubular configuration with proximate (38) and distal ends (40) and a sheath ...


2
Zamierowski David S: Pansement, A wound dressing. Zamierowski David S, Kci Licensing, FETHERSTONHAUGH & CO, November 26, 1992: CA2103033 (13 worldwide citation)

A fastening system includes a membrane assembly which can comprise a pair of body panels secured together at a seam. The membrane panels can comprise a semi-permeable material. A sheath assembly has a tubular configuration with proximate and distal ends and a sheath passage extending,therebetween. T ...


3
Winter Gregory Paul, Johnson Kevin Stuart, Griffiths Andrew David, Smith Andrew John Hammond: Methods for producing members of specific binding pairs. Cambridge Antibody Technology, Medical Research Council, Winter Gregory Paul, Johnson Kevin Stuart, Griffiths Andrew David, Smith Andrew John Hammond, ARMITAGE Ian M, November 26, 1992: WO/1992/020791 (5 worldwide citation)

The invention provides methods and kits for producing specific binding pairs (sbp) members. Populations of polypeptide chain components of sbp members are combined to form libraries of sbps displayed by secreted replicable genetic display packages (rgdp). At least one of the polypeptide chains is ex ...


4
Shiao Shin Jen, Lin Chun Hong: Polymer based selflubricating composite. Shiao Shin Jen, Lin Chun Hong, BEDNAREK Michael D, November 26, 1992: WO/1992/020736 (4 worldwide citation)

Disclosed is a selflubricating composite material prepared from polymers, liquid lubricant and solid compound, used for the fabrication of bearing members. The composite material is characterized by solid compound contained therein and has been treated with titanates or silane compounds and mixed wi ...


5
Boon Thierry, Van Der, Bruggen Pierre, Van Den, Eynde Benoit, Van, Pel Aline, de, Plaen Etienne, Lurquin Christophe, Chomez Patrick, Traversari Catia: Tumor rejection antigen precursors, tumor rejection antigens and uses thereof. Ludwig Institute For Cancer Research, Boon Thierry, Van Der, Bruggen Pierre, Van Den, Eynde Benoit, Van, Pel Aline, de, Plaen Etienne, Lurquin Christophe, Chomez Patrick, Traversari Catia, HANSON Norman D, November 26, 1992: WO/1992/020356 (3 worldwide citation)

The invention relates to an isolated DNA sequence which codes for an antigen expressed by tumor cells which is recognized by cytotoxic T cells, leading to lysis of the tumor which expresses it. Also described are cells transfected by the DNA sequence, and various therapeutic and diagnostic uses aris ...


6
Colthurst James: Nasal cannula. Calor Air Separation, Colthurst James, HYDE HEIDE 10 12 Priests Bridge London SW15 5JE, November 26, 1992: WO/1992/020392 (3 worldwide citation)

A nasal cannula comprising a generally tubular insert element which has a distal portion (4) to be placed in a nasal cavity and a proximal portion (2) for connection to a supply line (10) for oxygen or oxygen-enriched gas is characterised in by the distal portion (4) being formed of a flexible and r ...


7
Le, Mitouard Anne: (Fr) Masque respiratoire facial, (En) Facial breathing mask. Le, Mitouard Anne, ROBERT Jean Pierre, November 26, 1992: WO/1992/020395 (3 worldwide citation)

(EN) The facial mask of the invention is provided with means arranged between an inspiration-expiration tube (10) and at least one of the nose and mouth orifices of the patient (5) in order to provide for a sealed connection between the pipe and the respiratory tract of the patient, said means compr ...


8
Spada Alfred P, Maguire Martin P, Persons Paul E, Myers Michael R: Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase. Rhone Poulenc Rorer International, Spada Alfred P, Maguire Martin P, Persons Paul E, Myers Michael R, NICHOLSON James A, November 26, 1992: WO/1992/020642 (3 worldwide citation)

This invention relates to bis mono- and/or bicyclic aryl and/or heteroaryl compounds exhibiting protein tyrosine kinase inhibition activity. More specifically, it relates to the method of inhibiting abnormal cell proliferation in a patient suffering from a disorder characterized by such proliferatio ...


9
Kiemowitz Rudolph M, Fitzgerald Desmond J: Suppression des niveaux du thromboxane par ladministration percutanee daspirine, Suppression of thromboxane levels by percutaneous administration of aspirin. Gundersen Medical Foundation, Vanderbilt University, Vanderbilt University, Keimowitz Rudolph, BORDEN LADNER GERVAIS, November 26, 1992: CA2107587 (3 worldwide citation)

A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing the therapeutic methods of the invention are also disclosed.


10
Buchardt Ole, Egholm Michael, Nielsen Peter Eigil, Berg Rolf Henrik: Peptide nucleic acids. Buchardt Ole, Egholm Michael, Nielsen Peter Eigil, Berg Rolf Henrik, HALLYBONE Huw George, November 26, 1992: WO/1992/020702 (2 worldwide citation)

A novel class of compounds, known as peptide nucleic acids, bind complementary ssDNA and RNA strands more strongly than a corresponding DNA. The peptide nucleic acids generally comprise ligands such as naturally occurring DNA bases attached to a peptide backbone through a suitable linker.